Private company
BML Investment Partners, L.P.
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
BML Investment Partners, L.P. sits at the top of its group. 46 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- BML Investment Partners, L.P. DE
- AcelRx Pharmaceuticals (United States) Stake · Redwood City
- Achilles Therapeutics plc Stake · Birmingham, United Kingdom
- Aclaris Therapeutics, Inc. Stake · Wayne, Pennsylvania, United States
- AN2 Therapeutics, Inc. Stake · Menlo Park, California
- Astrotech Corporation Stake · Wilmington, Delaware, United States
- Atea Pharmaceuticals, Inc. Stake · Boston, Massachusetts
- Avalanche Biotechnologies Stake · Redwood City
- CalciMedica, Inc. Stake · La Jolla, California
- Climb Bio, Inc. Stake · Wellesley Hills, Massachusetts
- Connect Biopharma Holdings Ltd Stake · San Diego, California
- Cyteir Therapeutics, Inc. Stake · Stoneham, Massachusetts
- Disc Medicine, Inc. Stake · Watertown, Massachusetts
- Elevation Oncology, Inc. Stake · Boston, Massachusetts
- Embark Technology Stake · San Francisco, California, United States
- enGene Therapeutics Inc. Stake · Z4
- Enliven Therapeutics, Inc. Stake · Burlingame, California
- Essa Pharma (United States) Stake · Houston
- Forte Biosciences, Inc. Stake · San Diego, California, United States
- ImageneBio, Inc. Stake · San Diego, California
- Instil Bio, Inc. Stake · Dover, Delaware, United States
- IRulya Therapeutics Inc. Stake · New Haven, Connecticut
- Kezar Life Sciences, Inc. Stake · South San Francisco, California, United States
- LAVA Therapeutics NV Stake · P7
- LeonaBio, Inc. Stake · Bothell, Washington
- Luby's Stake · Houston, Texas, United States
- and 20 more
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (45 companies). Each entity in the chart links to its source.
Stakes it holds
BML Investment Partners, L.P. has told the SEC it owns more than 5% of 45 companies, latest first (Schedules 13D and 13G).
- Connect Biopharma Holdings LtdSCHEDULE 13G Oct 6, 20262
- Outset Medical, Inc.SCHEDULE 13G/A Jan 14, 2026 to Oct 6, 20263
- Oramed PharmaceuticalsSCHEDULE 13G/A Sep 16, 2024 to Jun 29, 20264
- enGene Therapeutics Inc.SCHEDULE 13G/A May 13, 2026 to May 14, 20265
- Kezar Life Sciences, Inc.SCHEDULE 13G/A Mar 6, 2025 to May 12, 20266
- Aclaris Therapeutics, Inc.SCHEDULE 13G/A Jan 16, 2024 to Apr 27, 20267
- TillysSCHEDULE 13G Jan 27, 2022 to Mar 19, 20268
- Atea Pharmaceuticals, Inc.SCHEDULE 13G Oct 2, 2023 to Feb 9, 20269
- Instil Bio, Inc.SCHEDULE 13G/A Apr 2, 2024 to Feb 9, 202610
- PMV Pharmaceuticals, Inc.SCHEDULE 13G/A Dec 12, 2024 to Feb 9, 202611
- LeonaBio, Inc.SCHEDULE 13G/A Nov 7, 2024 to Dec 18, 202512
- Avalanche BiotechnologiesSCHEDULE 13D/A May 10, 2022 to Dec 9, 202513
- Astrotech CorporationSCHEDULE 13D/A Mar 3, 2022 to Oct 7, 202514
- Elevation Oncology, Inc.SCHEDULE 13D/A Mar 26, 2025 to Jul 28, 202515
- ImageneBio, Inc.SCHEDULE 13D/A Dec 31, 2024 to Jul 28, 202516
- AN2 Therapeutics, Inc.SCHEDULE 13D/A Aug 12, 2024 to Jun 18, 202517
- Essa Pharma (United States)SCHEDULE 13D Nov 7, 2024 to Apr 24, 202518
- Whitehawk Therapeutics, Inc.SCHEDULE 13D/A Aug 28, 2024 to Mar 5, 202519
- LAVA Therapeutics NVSCHEDULE 13G Mar 3, 202520
- Third Harmonic Bio, Inc.SCHEDULE 13G Feb 14, 202521
- Achilles Therapeutics plcSCHEDULE 13G/A Sep 25, 2024 to Feb 13, 202522
- Climb Bio, Inc.SCHEDULE 13G/A May 4, 2022 to Feb 13, 202523
- Tectonic Therapeutic, Inc.SCHEDULE 13G/A Jul 24, 2023 to Feb 13, 202524
- OnKure Therapeutics, Inc.SC 13G/A Jan 17, 2024 to Oct 9, 202425
- Talis Biomedical CorpSC 13G/A Aug 14, 202426
- Cyteir Therapeutics, Inc.SC 13G/A Jan 26, 2023 to Mar 19, 202427
- CalciMedica, Inc.SC 13G/A Dec 1, 2022 to Feb 7, 202428
- Enliven Therapeutics, Inc.SC 13G/A Apr 14, 2022 to Feb 7, 202429
- IRulya Therapeutics Inc.SC 13G/A Jul 17, 2023 to Feb 7, 202430
- Oruka Therapeutics, Inc.SC 13G/A Jan 27, 2022 to Feb 7, 202431
All 45 companies
- Surrozen, Inc./DESC 13G/A Feb 2, 2023 to Feb 7, 202432
- Tourmaline Bio, Inc.SC 13G/A Apr 27, 2023 to Feb 7, 202433
- Forte Biosciences, Inc.SC 13D/A May 4, 2022 to Jan 11, 202434
- Rain Oncology Inc.SC 13G Nov 24, 202335
- Satsuma Pharmaceuticals, Inc.SC 13G/A Nov 16, 2022 to Jun 13, 202336
- Embark TechnologySC 13G Mar 17, 202337
- Metacrine, Inc.SC 13G/A Feb 18, 2022 to Feb 8, 202338
- PARDES BIOSCIENCES, INC.SC 13G/A Dec 30, 2022 to Feb 8, 202339
- RETRACTABLE TECHNOLOGIES INCSC 13G/A Jan 27, 2022 to Feb 8, 202340
- Richardson ElectronicsSC 13G/A Jan 27, 2022 to Feb 8, 202341
- Terns Pharmaceuticals, Inc.SC 13G/A Jun 7, 2022 to Feb 8, 202342
- Disc Medicine, Inc.SC 13G Mar 10, 2022 to Jan 9, 202343
- Odonate Therapeutics, Inc.SC 13G/A Jan 28, 202244
- AcelRx Pharmaceuticals (United States)SC 13G/A Jan 27, 202245
- Luby'sSC 13G/A Jan 27, 202246
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46